2017 American Transplant Congress
Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients.
Intro: CNIs improve kidney transplant (KT) survival, but have significant toxicities, including graft dysfunction (GD), neurotoxicity (NT), or thrombotic microangiopathy (TMA). Belatacept is an alternative…2017 American Transplant Congress
Genomic Diversity of Epstein-Barr Virus in Post-Transplant Lymphoproliferative Disorder.
Program in Immunology, Stanford University School of Medicine, Stanford, CA
Purpose: In transplant recipients, Epstein-Barr Virus (EBV) is associated with the development of B cell lymphomas in post-transplant lymphoproliferative disorder (PTLD). We used next-generation sequencing…2017 American Transplant Congress
Donor SIRPa Polymorphism Modulates the Innate Immune Response to Allogeneic Grafts.
Mice devoid of T, B, NK, and innate lymphoid cells distinguish between self and allogeneic non-self despite the absence of an adaptive immune system. When…2017 American Transplant Congress
Urinary Proteomic Biomarkers Discovery for Prediction of Acute Rejection in Kidney Transplant Recipients.
Internal Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea
Background: Early prediction and treatment of acute rejection are crucial in kidney transplant recipients (KTRs) to prevent allograft loss. Changes in the serum and urinary…2017 American Transplant Congress
A Novel Computational HLA Matching Algorithm for Improving Donor-Recipient Histocompatibility and Graft Outcomes After Kidney Transplantation.
Introduction: Human Leukocyte Antigen (HLA) matching is a central objective of kidney allocation policies, but current assessment of histocompatibility is inadequate. Building on our previous…2017 American Transplant Congress
Suppression of Inflammation by Withaferin A in Cerulein-Induced Pancreatitis Model Results in Improved Syngeneic Islet Engraftment.
Introduction: Chronic pancreatitis (CP) is characterized by inflammatory damage to acinar cells followed by islets. In clinical islet autotransplantation, patients with advanced stages of CP…2017 American Transplant Congress
Comparing Outcomes of ABO Incompatible to DSA Positive/CDC-AHG Negative Kidney Transplantation.
Back ground: Desensitization provides benefit in high risk kidney transplant recipients. We evaluated one year outcomes, including substances removal by apheresis techniques of ABO incompatible…2017 American Transplant Congress
Comparison of Locoregional Therapies for Hepatocellular Carcinoma in Liver Transplant Recipients.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD
Background: Locoregional therapies (LRT) have been employed in patients with hepatocellular carcinoma (HCC) to halt tumor progression and prevent waitlist drop out, as well as…2017 American Transplant Congress
OPO Performance Metrics: Relationship with Kidney Transplant Program Performance Metrics and Kidney Utilization.
Scientific Registry of Transplant Recipients, Minneapolis, MN
Organ procurement organization (OPO) performance metrics have been scrutinized due to the perceived disincentives of the regulatory system. In kidney transplantation, OPOs are evaluated on…2017 American Transplant Congress
Impact of a Novel Prehabilitation Program in Kidney Transplant Candidates.
Background: Prehabilitation is the process of enhancing surgical patient functional capacity prior to surgery to improve tolerance for the upcoming physiologic stress. While prehabilitation has…
- « Previous Page
- 1
- …
- 104
- 105
- 106
- 107
- 108
- …
- 181
- Next Page »